Tae G - Search Results

1

Effect of C-terminus Conjugation via Different Conjugation Chemistries on In Vivo Activity of Albumin-Conjugated Recombinant GLP-1.

Park J, Bak M, Min K, Kim HW, Cho JH, Tae G, Kwon I. Park J, et al. Among authors: tae g. Pharmaceutics. 2021 Feb 15;13(2):263. doi: 10.3390/pharmaceutics13020263. Pharmaceutics. 2021. PMID: 33672039 Free PMC article.

2

Site-Specific Albumination as an Alternative to PEGylation for the Enhanced Serum Half-Life in Vivo.

Yang B, Lim SI, Kim JC, Tae G, Kwon I. Yang B, et al. Among authors: tae g. Biomacromolecules. 2016 May 9;17(5):1811-7. doi: 10.1021/acs.biomac.6b00238. Epub 2016 Apr 15. Biomacromolecules. 2016. PMID: 27050863

3

In situ formation of injectable and porous heparin-based hydrogel.

Goh M, Kim Y, Gwon K, Min K, Hwang Y, Tae G. Goh M, et al. Among authors: tae g. Carbohydr Polym. 2017 Oct 15;174:990-998. doi: 10.1016/j.carbpol.2017.06.126. Epub 2017 Jul 12. Carbohydr Polym. 2017. PMID: 28821157

4

Comparative studies of the serum half-life extension of a protein via site-specific conjugation to a species-matched or -mismatched albumin.

Yang B , Kim JC , Seong J , Tae G , Kwon I . Yang B , et al. Among authors: tae g. Biomater Sci. 2018 Jul 24;6(8):2092-2100. doi: 10.1039/c8bm00456k. Biomater Sci. 2018. PMID: 29881837

5

Rapid and Versatile Cell Aggregate Formation Using Lipid-Conjugated Heparin.

Kim E, Kim JC, Min K, Goh M, Tae G. Kim E, et al. Among authors: tae g. ACS Appl Mater Interfaces. 2018 Jul 25;10(29):24431-24439. doi: 10.1021/acsami.8b07731. Epub 2018 Jul 13. ACS Appl Mater Interfaces. 2018. PMID: 29953811

6

An injectable and physical levan-based hydrogel as a dermal filler for soft tissue augmentation.

Choi WI , Hwang Y , Sahu A , Min K , Sung D , Tae G , Chang JH . Choi WI , et al. Among authors: tae g. Biomater Sci. 2018 Sep 25;6(10):2627-2638. doi: 10.1039/c8bm00524a. Biomater Sci. 2018. PMID: 30109875

7

Co-delivery of therapeutic protein and catalase-mimic nanoparticle using a biocompatible nanocarrier for enhanced therapeutic effect.

Kim S, Kim M, Jung S, Kwon K, Park J, Kim S, Kwon I, Tae G. Kim S, et al. Among authors: tae g. J Control Release. 2019 Sep 10;309:181-189. doi: 10.1016/j.jconrel.2019.07.038. Epub 2019 Jul 26. J Control Release. 2019. PMID: 31356840

8

Improving cancer therapy through the nanomaterials-assisted alleviation of hypoxia.

Sahu A, Kwon I, Tae G. Sahu A, et al. Among authors: tae g. Biomaterials. 2020 Jan;228:119578. doi: 10.1016/j.biomaterials.2019.119578. Epub 2019 Oct 29. Biomaterials. 2020. PMID: 31678843 Review.

9

Intramolecular distance in the conjugate of urate oxidase and fatty acid governs FcRn binding and serum half-life in vivo.

Cho J, Park J, Kim S, Kim JC, Tae G, Jin MS, Kwon I. Cho J, et al. Among authors: tae g. J Control Release. 2020 May 10;321:49-58. doi: 10.1016/j.jconrel.2020.01.034. Epub 2020 Jan 30. J Control Release. 2020. PMID: 32006589

10

Recombinant Peptide Production Platform Coupled with Site-Specific Albumin Conjugation Enables a Convenient Production of Long-Acting Therapeutic Peptide.

Bak M, Park J, Min K, Cho J, Seong J, Hahn YS, Tae G, Kwon I. Bak M, et al. Among authors: tae g. Pharmaceutics. 2020 Apr 16;12(4):364. doi: 10.3390/pharmaceutics12040364. Pharmaceutics. 2020. PMID: 32316169 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

132 results

Search Page

Filters